Literature DB >> 7916240

Bladder cancer: the molecular progression to invasive disease.

A R Simoneau1, P A Jones.   

Abstract

Recent investigations have given a clearer insight into the genetic progression of bladder cancer. In this review we identify the clinical courses of bladder cancer, review the basic concepts of carcinogenesis, and focus on the specific cytogenetic and molecular alterations observed in bladder cancer. Progression models to superficial and invasive disease are discussed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7916240     DOI： 10.1007/bf00184243

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  54 in total

Review 1.  The epidemiology of bladder cancer: a second look.

Authors:  E L Wynder; R Goldsmith
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

Review 2.  Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms.

Authors:  P A Jones; M J Droller
Journal:  Semin Urol       Date:  1993-11

3.  The influence of retinoic acid receptor (RAR) status of bladder tumours on the course of the disease.

Authors:  A R de Bolla; R M Shave; S L Fagg; K Heald; M A Hughes; D M Wallace; P D Edwards
Journal:  Br J Urol       Date:  1985-12

4.  Cytogenetic studies of carcinoma in situ of the bladder: prognostic implications.

Authors:  M Tyrkus; I Powell; W Fakr
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

5.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.

Authors:  J M Horowitz; S H Park; E Bogenmann; J C Cheng; D W Yandell; F J Kaye; J D Minna; T P Dryja; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

7.  Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.

Authors:  A F Althausen; G R Prout; J J Daly
Journal:  J Urol       Date:  1976-11       Impact factor: 7.450

8.  Preliminary mapping of the deleted region of chromosome 9 in bladder cancer.

Authors:  P Cairns; M E Shaw; M A Knowles
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

9.  Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.

Authors:  P Cairns; A J Proctor; M A Knowles
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

10.  Maintenance of p53 alterations throughout breast cancer progression.

Authors:  A M Davidoff; B J Kerns; J D Iglehart; J R Marks
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701
View more
  5 in total

1.  Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.

Authors:  Tadeusz Majewski; Sangkyou Lee; Joon Jeong; Dong-Sup Yoon; Andrzej Kram; Mi-Sook Kim; Tomasz Tuziak; Jolanta Bondaruk; Sooyong Lee; Weon-Seo Park; Kuang S Tang; Woonbok Chung; Lanlan Shen; Saira S Ahmed; Dennis A Johnston; H Barton Grossman; Colin P Dinney; Jain-Hua Zhou; R Alan Harris; Carrie Snyder; Slawomir Filipek; Steven A Narod; Patrice Watson; Henry T Lynch; Adi Gazdar; Menashe Bar-Eli; Xifeng F Wu; David J McConkey; Keith Baggerly; Jean-Pierre Issa; William F Benedict; Steven E Scherer; Bogdan Czerniak
Journal:  Lab Invest       Date:  2008-05-05       Impact factor: 5.662

2.  LOH detected by microsatellite markers reveals the clonal origin of recurrent laryngeal squamous cell carcinoma.

Authors:  Zhaoyang Cui; Xinliang Pan; Qirong Wang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

3.  Urinary bladder lesions after the Chernobyl accident: immunohistochemical assessment of p53, proliferating cell nuclear antigen, cyclin D1 and p21WAF1/Cip1.

Authors:  A Romanenko; C C Lee; S Yamamoto; T Hori; H Wanibuchi; W Zaparin; W Vinnichenko; A Vozianov; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1999-02

4.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

5.  Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer.

Authors:  Rajkumar S Kalra; Sharmila A Bapat
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.